Anson Funds Management LP 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 9:41 pm Sale | 2025-06-30 | 13G | HEPION PHARMACEUTICALS INC HEPA | Anson Funds Management LP | 576,482 4.900% | -19,237 (-3.23%) | Filing |
| 2025-05-15 5:23 pm Purchase | 2025-03-31 | 13G | HEPION PHARMACEUTICALS INC HEPA | Anson Funds Management LP | 595,719 9.900% | 595,538 (+329026.52%) | Filing |